相关实验视频
Updated: Jun 7, 2025

08:48
Author Spotlight: Decoding Mitochondrial Aging
Published on: June 30, 2023
3.6K
线粒体DAMP:神经炎症和神经退行性疾病发病的关键媒介
Haihan Yu1, Kaidi Ren2, Yage Jin3
1Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, PR China.
Neuropharmacology
|November 18, 2024
概括
线粒体损伤相关的分子模式 (mtDAMPs) 在阿尔茨海默氏症和帕金森症等神经退行性疾病中驱动神经炎症. 针对这些mtDAMP提供了一个有希望的治疗策略,可以减缓疾病的进展.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 神经退行性疾病 (阿尔茨海默病,帕金森病,亨廷顿病,ALS) 与线粒体功能障碍和神经炎症有关.
- 线粒体损伤相关的分子模式 (mtDAMPs) 是关键的调解者,将线粒体压力与炎症反应联系起来.
研究的目的:
- 审查mtDAMPs诱导神经炎症的机制.
- 讨论针对mtDAMP驱动路径的治疗策略.
- 为了探索线粒体-免疫系统交叉谈话在神经退行.
主要方法:
- 文献综述侧重于线粒体功能障碍,神经炎症和mtDAMPs.
- 通过mtDAMPs激活的炎症通路 (NLRP3炎症体,cGAS-STING) 的分析.
- 在这些途径中探索治疗点.
主要成果:
- 从受损的线粒体中释放的mtDAMPs (mtDNA,ATP,ROS) 激活了先天免疫路径.
- 激活NLRP3炎症体和cGAS-STING等通路会加剧神经炎症和神经元损伤.
- 线粒体和免疫系统之间的复杂相互作用有助于疾病的进展.
结论:
- mtDAMPs是神经退行性疾病中神经炎症的关键驱动因素.
- 准mtDAMP介导的炎症途径提供了一个新的治疗途径.
- 通过mtDAMP途径调节神经炎症可以减缓疾病的进展并改善结果.
相关概念视频
Mitochondrial Membranes
8.9K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
8.9K
Mitochondria
11.2K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
11.2K
Electron Transport Chain: Complex I and II
11.9K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
11.9K
Translocation of Proteins into the Mitochondria
3.0K
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
3.0K
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
Parkinson's Disease: Overview
482
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
482

